Method of operating and endpoint-qualifying a solid-state battery cell

The solid-state battery sector is entering a phase where the race to market is being won not just by whoever discovers the best electrolyte material, but by whoever can demonstrate controlled, reproducible cell operation at conditions that qualify for automotive and consumer-electronics product specifications. Method-of-use claims covering defined operating protocols — including specified C-rates, stack pressures, and confirmable endpoint metrics — represent a distinct and often underappreciated layer of intellectual property that sits above compositional claims. This asset is precisely that layer: a method claim tied to the operation of the integrated all-solid-state cell disclosed in the broader portfolio of solid-state battery electrolytes and interfaces, cycling the assembled cell across a defined C-rate envelope (C/20 through 3C) under controlled stack pressure (0.1 to 10 MPa) within cathode-appropriate voltage windows, and confirming that at least one of a defined set of measurable endpoints — critical current density, interfacial resistance, capacity retention, coulombic efficiency, or EDS elemental-gradient characterization — satisfies an operative threshold. The strategic purpose of a method-of-use claim of this type is to extend the reach of a patent portfolio beyond the composition or apparatus into the act of commercially operating the cell. A competitor or licensee who makes, uses, sells, or imports the integrated cell and then runs it under these conditions — which correspond to the commercially relevant operating regime for virtually every serious ASSB development program — would practice this claim. This is meaningful because the operating conditions themselves are not arbitrary: the 0.1 to 10 MPa pressure range corresponds to the stack-pressure requirements for solid electrolyte contact integrity, and the C/20 to 3C range spans both formation cycling and the fast-charge conditions that differentiate competitive solid-state cells. The endpoint metrics are not decorative; each one maps directly to a specification that OEM procurement teams and cell certifiers actually measure. Positioned within the solid-state battery electrolytes and interfaces portfolio, this method claim functions as an operational envelope that ties together the compositional and structural innovations claimed elsewhere in the family. It is honest to describe it as a method-of-use vessel — a claim whose value derives from its connection to the underlying cell claims — rather than a standalone foundational discovery. Nevertheless, method-of-use claims of this structure have demonstrated substantial licensing leverage in adjacent battery technologies, and their value scales directly with the adoption of the underlying cell architecture.

This method claim does not describe a new material or structure; it describes a defined operating protocol applied to the integrated all-solid-state cell disclosed elsewhere in the portfolio. The technical substance lies in the precision of the operating window and the specificity of the endpoint thresholds. The C-rate range of C/20 to 3C is deliberately broad enough to encompass the full lifecycle of cell operation — from slow-rate formation protocols (C/20) through moderate discharge (C/2, 1C) to aggressive fast-charge and pulse conditions (3C) — while remaining narrow enough to exclude trivially slow self-discharge regimes. This breadth is intentional: it captures the operating conditions that commercial cell developers actually use, without extending into physically implausible regimes that a court would find non-enabling. Stack pressure in the range of 0.1 to 10 MPa is the technically meaningful window for maintaining solid-solid contact at the electrolyte-electrode interface in sulfide, oxide, and polymer-ceramic composite solid electrolytes. Below roughly 0.1 MPa, contact resistance rises sharply and delamination during cycling becomes a failure mode. Above 10 MPa, electrode cracking and electrolyte fracture become concerns, and the mechanical design of the cell housing must change substantially. The claimed pressure window therefore captures the engineering-feasible regime for a commercially manufacturable stack. The cathode-selected voltage window provision is technically important because it acknowledges that the upper cutoff voltage must be matched to the active cathode material — a lithium-nickel-manganese-oxide layered cathode has a different cutoff than a lithium-iron-phosphate system — and that the claim should read on any cathode-compatible operating protocol rather than locking to a single chemistry. The endpoint confirmation requirements are the most technically distinctive aspect of the claim. Critical current density (CCD) is the threshold current density above which lithium dendrite propagation through the solid electrolyte becomes irreversible — it is arguably the single most important electrochemical qualification metric for solid electrolyte adoption in lithium-metal cells. Interfacial resistance measured by impedance spectroscopy directly quantifies the electrolyte-electrode contact quality and its evolution under cycling. Capacity retention and coulombic efficiency after a defined number of cycles are the standard acceptance criteria for cell qualification programs at automotive OEMs. The inclusion of EDS elemental-gradient confirmation — energy-dispersive X-ray spectroscopy cross-section analysis of the cycled interface — is a materials-characterization endpoint that bridges electrochemical performance with structural evidence, linking the method claim back to the compositional and microstructural claims in the portfolio. Together, these five endpoint metrics create a conjunctive "confirm at least one" structure that is both broad (any single metric suffices) and grounded in commercially relevant measurement practice. From a process-chemistry standpoint, the method also implicitly covers formation protocol design, which is a recognized source of intellectual property in lithium-ion cell manufacturing and is becoming equally important in solid-state cells where formation conditions govern the SEI and interface layer that develops between the lithium-metal anode and the solid electrolyte. The pressure conditioning during formation — a specific sub-regime of the 0.1 to 10 MPa envelope — influences grain-boundary contact, lithium deposition morphology, and the initial impedance state that determines subsequent cycle life. This makes the method claim relevant not only to cell operation in the field but to manufacturing-process qualification, a context in which method claims are particularly difficult to design around.

The addressable market for this asset must be understood through the lens of what method-of-use claims actually monetize: every commercial entity that manufactures, qualifies, and operates an all-solid-state cell of the type described in the portfolio, and does so under the specified conditions. That population currently includes automotive OEMs pursuing solid-state battery programs, consumer-electronics manufacturers developing solid-state cells for high-energy-density portable devices, defense and aerospace integrators requiring high-reliability energy storage, and the tier-1 battery cell manufacturers supplying all of the above. The estimated addressable market of $1 to 3 billion represents licensing revenue potential — royalty streams on cell production, one-time licensing fees for cell-operation IP, or settlement values in litigation contexts — across this OEM and cell-operator population, not total end-market revenue for solid-state batteries, which is forecast to reach tens of billions of dollars in the 2030s. The royalty logic for a method-of-use claim of this type typically runs on a per-cell or per-kWh basis, negotiated as part of a portfolio license that includes the underlying cell composition and structure claims. Standalone method-of-use claims rarely command the highest royalty rates, but they serve two commercial functions that justify their inclusion in a licensing package. First, they extend the portfolio's reach to entities that might design around the composition claims by sourcing electrolyte material from a different supplier — the method claim still reads on the act of operating the cell under the specified conditions. Second, they provide a basis for downstream licensing to cell integrators and OEMs who did not themselves make the cell but who operate it in a product, under a theory of direct infringement of the method. This two-layer coverage — manufacturer plus operator — is the structural reason method-of-use claims remain a standard element of battery patent portfolios despite being derivative of the underlying apparatus claims. The timing dynamic is material. Automotive OEMs including Toyota, Volkswagen, GM, and a cohort of Chinese manufacturers have publicly committed to solid-state battery production timelines in the 2027 to 2030 window. Consumer-electronics manufacturers are closer — Samsung SDI and Panasonic have indicated solid-state cell introductions for premium devices within the 2025 to 2027 range. Both of these forced-substitution timelines create licensing leverage windows: the period between technology commitment and production ramp is when IP positions are most actively evaluated, cross-licenses negotiated, and freedom-to-operate opinions commissioned. A portfolio that includes a method-of-use claim covering the standard qualification protocol — which is precisely what this asset provides — is more complete from a buyer's perspective than one that covers only the composition.

method-of-use coverage of the operated cell

ties operation to measurable endpoint thresholds of the operative claims

The most strategically aligned acquirers and licensees for this asset are automotive OEMs with active solid-state battery development programs who need portfolio coverage extending from cell composition through operation and qualification. Companies in this category include Toyota, which holds the largest global solid-state battery patent position but whose portfolio is primarily in composition and architecture, and Volkswagen-backed QuantumScape, which is in active cell development with oxide electrolyte systems. A method-of-use claim that reads on standard cell qualification protocols — and that connects to a portfolio of underlying composition and structure claims — adds value to any strategic acquirer whose goal is to control IP across the full cell development and commercialization stack. Tier-1 cell manufacturers supplying the automotive OEM market, including Samsung SDI, Panasonic, and CATL, are natural licensees who would seek to clear or acquire this claim as part of pre-production IP due diligence. Consumer-electronics and wearable device manufacturers are a secondary but real buyer category. The operating conditions specified — particularly the C/20 to 3C range and the coulombic efficiency and capacity retention endpoints — are equally applicable to small-format solid-state cells for smartphones and wearables. For a licensing strategy, the most efficient path is bundling this method claim with the underlying apparatus and composition claims in the portfolio as a package license, rather than attempting to license the method claim in isolation, where its value is substantially diminished without the underlying cell claims. For an outright acquisition, the portfolio as a whole — including this method claim as one of its operational layers — would be the natural unit of transaction.

The primary risk for this asset is its dependency on the underlying cell claims. A method-of-use claim that references the "cell of" a defined set of operative claims is only as strong as those claims. If the underlying cell claims face prior-art challenges, restriction requirements, or narrowing during prosecution or post-grant review, the scope of the method claim narrows correspondingly or may require amendment. This is not a unique risk for this asset — it is structural to the method-of-use claim form — but it means that a buyer evaluating this asset must assess the strength of the underlying cell claims, not just the method claim in isolation. The honest characterization of this asset is that it is a reinforcing layer, not a standalone pillar. The second risk is the open experimental validation gate. Until measured cycling data under the specified conditions is generated, the method claim lacks the commercial weight that comes from being able to demonstrate in a licensing or litigation context that the claimed endpoint thresholds are achievable and reproducible. The de-risking roadmap is straightforward: conduct a structured rate-capability and cycle-life test on assembled cells under the claimed pressure and voltage window conditions, measure all five endpoint metrics, and document threshold satisfaction. This is standard cell characterization work that any well-equipped battery laboratory can execute. Completion of that experimental dataset would substantially increase the claim's commercial readiness and is the single highest-priority action item for this asset.